Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Rimawi, M.F."'
Autor:
Wapnir, I.L., Price, K.N., Anderson, S.J., Robidoux, A., Martin, M., Nortier, J.W.R., Paterson, A.H.G., Rimawi, M.F., Lang, I., Baena-Canada, J.M., Thurlimann, B., Mamounas, E.P., Geyer, C.E., Gelber, S., Coates, A.S., Gelber, R.D., Rastogi, P., Regan, M.M., Wolmark, N., Aebi, S., NRG Oncology, GEICAM Spanish Breast Canc Grp, BOOG Dutch Breast Canc Trialists G, Breast Int Grp
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Wapnir, Irene L.; Price, Karen N.; Anderson, Stewart J.; Robidoux, André; Martín, Miguel; Nortier, Johan W.R.; Paterson, Alexander H.G.; Rimawi, Mothaffar F.; Láng, István; Baena-Cañada, José Manuel; Thürlimann, Beat; Mamounas, Eleftherios P.; Geyer, Charles E.; Gelber, Shari; Coates, Alan S.; Gelber, Richard D.; Rastogi, Priya; Regan, Meredith M.; Wolmark, Norman and Aebi, Stefan (2018). Efficacy of Chemotherapy for ER-Negative and ER-Positive Isolated Locoregional Recurrence of Breast Cancer: Final Analysis of the CALOR Trial. Journal of clinical oncology, 36(11), pp. 1073-1079. American Society of Clinical Oncology 10.1200/JCO.2017.76.5719
Journal of Clinical Oncology, 36(11), 1073
Consejería de Sanidad de la Comunidad de Madrid
Wapnir, Irene L.; Price, Karen N.; Anderson, Stewart J.; Robidoux, André; Martín, Miguel; Nortier, Johan W.R.; Paterson, Alexander H.G.; Rimawi, Mothaffar F.; Láng, István; Baena-Cañada, José Manuel; Thürlimann, Beat; Mamounas, Eleftherios P.; Geyer, Charles E.; Gelber, Shari; Coates, Alan S.; Gelber, Richard D.; Rastogi, Priya; Regan, Meredith M.; Wolmark, Norman and Aebi, Stefan (2018). Efficacy of Chemotherapy for ER-Negative and ER-Positive Isolated Locoregional Recurrence of Breast Cancer: Final Analysis of the CALOR Trial. Journal of clinical oncology, 36(11), pp. 1073-1079. American Society of Clinical Oncology 10.1200/JCO.2017.76.5719
Journal of Clinical Oncology, 36(11), 1073
Purpose Isolated locoregional recurrence (ILRR) predicts a high risk of developing breast cancer distant metastases and death. The Chemotherapy as Adjuvant for LOcally Recurrent breast cancer (CALOR) trial investigated the effectiveness of chemothera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2327f8cae94167a669ba562dac704cae
https://hdl.handle.net/20.500.12530/37770
https://hdl.handle.net/20.500.12530/37770
Autor:
Aebi, S., Gelber, S., Anderson, S.J., Lang, I., Robidoux, A., Martin, M., Nortier, J.W.R., Paterson, A.H.G., Rimawi, M.F., Canada, J.M.B., Thurlimann, B., Murray, E., Mamounas, E.P., Geyer, C.E., Price, K.N., Coates, A.S., Gelber, R.D., Rastogi, P., Wolmark, N., Wapnir, I.L., CALOR Investigators
Publikováno v:
The Lancet Oncology, 15(2), 156-163
Summary Background Patients with isolated locoregional recurrences (ILRR) of breast cancer have a high risk of distant metastasis and death from breast cancer. We aimed to establish whether adjuvant chemotherapy improves the outcome of such patients.